Chevalier Brett S, Kortemme Tanja, Chadsey Meggen S, Baker David, Monnat Raymond J, Stoddard Barry L
Fred Hutchinson Cancer Research Center and Graduate Program in Molecular and Cell Biology, University of Washington, 1100 Fairview Avenue N. A3-023, Seattle, WA 98109, USA.
Mol Cell. 2002 Oct;10(4):895-905. doi: 10.1016/s1097-2765(02)00690-1.
We have generated an artificial highly specific endonuclease by fusing domains of homing endonucleases I-DmoI and I-CreI and creating a new 1400 A(2) protein interface between these domains. Protein engineering was accomplished by combining computational redesign and an in vivo protein-folding screen. The resulting enzyme, E-DreI (Engineered I-DmoI/I-CreI), binds a long chimeric DNA target site with nanomolar affinity, cleaving it precisely at a rate equivalent to its natural parents. The structure of an E-DreI/DNA complex demonstrates the accuracy of the protein interface redesign algorithm and reveals how catalytic function is maintained during the creation of the new endonuclease. These results indicate that it may be possible to generate novel highly specific DNA binding proteins from homing endonucleases.
我们通过融合归巢内切酶I-DmoI和I-CreI的结构域,并在这些结构域之间创建一个新的1400 Ų的蛋白质界面,生成了一种人工高度特异性内切酶。蛋白质工程是通过结合计算重新设计和体内蛋白质折叠筛选来完成的。所得的酶E-DreI(工程化的I-DmoI/I-CreI)以纳摩尔亲和力结合一个长的嵌合DNA靶位点,并以与其天然亲本相当的速率精确切割它。E-DreI/DNA复合物的结构证明了蛋白质界面重新设计算法的准确性,并揭示了在新内切酶创建过程中催化功能是如何维持的。这些结果表明,从归巢内切酶中生成新型高度特异性DNA结合蛋白可能是可行的。